Skip to main content

Table 1 Patient core data

From: Sex-specific issues of central and peripheral arginine-vasopressin concentrations in neurocritical care patients

Age

[years]

Sex

Sodium

[mmol/l]

Hematocrit

[%]

GOS

AVP Plasma

[pg/ml]

AVP CSF

[pg/ml]

AVP Saliva

[pg/ml]

40

F

139

31.8

4

3.59

2.93

1.88

49

F

132

31.6

3

2.85

4.11

1.52

50

F

141

27.1

3

7.13

3.29

0.92

51

F

144

22.7

3

2.10

2.18

1.71

55

F

135

26.3

3

2.25

3.55

2.61

56

F

139

24.8

3

2.10

2.79

1.86

57

F

144

27.6

3

1.22

3.00

3.99

58

F

140

34.4

2

1.36

1.87

4.66

61

F

138

35.1

5

1.74

2.46

1.76

66

F

128

24.2

3

3.27

3.95

1.19

69

F

145

38.2

3

3.01

3.02

1.01

75

F

138

24.1

2

2.49

3.11

2.09

76

F

145

28.3

1

2.93

1.95

1.68

76

F

138

29.2

3

7.18

3.91

2.96

79

F

137

23.0

3

3.09

5.01

1.51

80

F

136

27.9

3

2.22

3.73

2.36

86

F

142

26.9

1

2.29

2.75

1.27

38

M

144

27.6

2

5.02

4.91

1.35

42

M

144

22.3

3

3.22

1.99

0.90

42

M

139

28.8

2

4.11

2.99

0.91

50

M

141

33.6

2

3.10

3.18

1.41

53

M

142

33.0

3

1.09

6.51

1.04

59

M

139

37.4

5

3.12

3.14

2.42

59

M

135

29.9

3

2.33

2.10

1.72

66

M

136

30.2

2

2.14

4.40

1.67

78

M

142

23.6

3

1.14

2.68

1.03

80

M

133

31.2

2

2.61

3.87

1.09

80

M

141

28.4

3

2.42

3.71

1.25

81

M

139

25.1

2

5.40

1.62

2.90

85

M

154

24.3

2

3.45

8.54

4.52

  1. GOS Glasgow Outcome Score at discharge from ICU